| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMP binding | 3.19e-06 | 21 | 227 | 5 | GO:0016208 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | SLIT2 FBLN1 EFEMP1 PXDN HMCN2 FGG HSPG2 LAMA3 LAMA4 THBS1 HMCN1 | 1.07e-05 | 188 | 227 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.43e-05 | 5 | 227 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.83e-05 | 6 | 227 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | calcium ion binding | F10 C2CD5 SLIT2 FBLN1 EFEMP1 HMCN2 PCDH10 BAIAP3 NOTCH2 CACNA1E HSPG2 STAB2 PCDHGB5 DSG3 RHOT2 CUBN RAB44 THBS1 PPP2R3A HMCN1 CDH11 RASGRP2 | 4.78e-05 | 749 | 227 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 3.81e-04 | 13 | 227 | 3 | GO:0046975 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 3.83e-04 | 3 | 227 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 3.83e-04 | 3 | 227 | 2 | GO:0003872 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 2.14e-07 | 6 | 228 | 4 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 2.14e-07 | 6 | 228 | 4 | GO:0006015 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 1.28e-05 | 5 | 229 | 3 | GO:0002189 | |
| GeneOntologyCellularComponent | basement membrane | 6.05e-05 | 122 | 229 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | PML body | 7.19e-05 | 125 | 229 | 8 | GO:0016605 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAM11 TRIL SLIT2 FBLN1 EFEMP1 PXDN HMCN2 OTOGL SERPINB12 LRRN2 FGG HSPG2 ZAN LAMA3 LAMA4 MUC5B LGALS3BP THBS1 HMCN1 | 1.19e-04 | 656 | 229 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAM11 TRIL SLIT2 FBLN1 EFEMP1 PXDN HMCN2 OTOGL SERPINB12 LRRN2 FGG HSPG2 ZAN LAMA3 LAMA4 MUC5B LGALS3BP THBS1 HMCN1 | 1.24e-04 | 658 | 229 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 3.56e-04 | 3 | 229 | 2 | GO:0005945 | |
| Domain | EGF-like_dom | ADAM18 ADAM11 F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 ZAN LAMA3 LAMA4 ADAM30 CUBN THBS1 HMCN1 | 1.17e-08 | 249 | 228 | 17 | IPR000742 |
| Domain | EGF_1 | ADAM18 ADAM11 F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 ZAN LAMA3 LAMA4 ADAM30 CUBN THBS1 HMCN1 | 1.67e-08 | 255 | 228 | 17 | PS00022 |
| Domain | EGF-like_CS | ADAM18 ADAM11 F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 ZAN LAMA3 LAMA4 ADAM30 CUBN THBS1 HMCN1 | 2.35e-08 | 261 | 228 | 17 | IPR013032 |
| Domain | EGF_2 | ADAM18 ADAM11 F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 ZAN LAMA3 ADAM30 CUBN THBS1 HMCN1 | 1.75e-07 | 265 | 228 | 16 | PS01186 |
| Domain | EGF_3 | ADAM18 ADAM11 F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 ZAN ADAM30 CUBN THBS1 HMCN1 | 2.09e-07 | 235 | 228 | 15 | PS50026 |
| Domain | EGF_CA | F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 CUBN THBS1 HMCN1 | 3.02e-07 | 122 | 228 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | F10 SLIT2 FBLN1 EFEMP1 HMCN2 NOTCH2 HSPG2 STAB2 CUBN THBS1 HMCN1 | 3.56e-07 | 124 | 228 | 11 | IPR001881 |
| Domain | EGF | ADAM11 F10 SLIT2 FBLN1 EFEMP1 NOTCH2 HSPG2 STAB2 ZAN LAMA3 LAMA4 CUBN THBS1 HMCN1 | 1.23e-06 | 235 | 228 | 14 | SM00181 |
| Domain | PRPP_SYNTHASE | 1.80e-06 | 3 | 228 | 3 | PS00114 | |
| Domain | PRib_PP_synth_CS | 1.80e-06 | 3 | 228 | 3 | IPR000842 | |
| Domain | Ig_I-set | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR HSPG2 HMCN1 SIGLEC1 LRIT1 | 3.94e-06 | 190 | 228 | 12 | IPR013098 |
| Domain | I-set | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR HSPG2 HMCN1 SIGLEC1 LRIT1 | 3.94e-06 | 190 | 228 | 12 | PF07679 |
| Domain | IGc2 | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR SEMA4D HSPG2 HMCN1 SIGLEC1 LRIT1 | 6.67e-06 | 235 | 228 | 13 | SM00408 |
| Domain | Ig_sub2 | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR SEMA4D HSPG2 HMCN1 SIGLEC1 LRIT1 | 6.67e-06 | 235 | 228 | 13 | IPR003598 |
| Domain | - | TTC23L NAPG ODAD4 DELE1 TRRAP TRANK1 PEX5 CLUH TTC28 RMDN2 LRPPRC DNAJC3 | 9.46e-06 | 207 | 228 | 12 | 1.25.40.10 |
| Domain | Pribosyltran_N | 1.76e-05 | 5 | 228 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 1.76e-05 | 5 | 228 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 1.76e-05 | 5 | 228 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 1.76e-05 | 5 | 228 | 3 | IPR029099 | |
| Domain | EGF_Ca-bd_CS | 2.48e-05 | 97 | 228 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.88e-05 | 99 | 228 | 8 | PS01187 | |
| Domain | TPR-like_helical_dom | TTC23L NAPG ODAD4 DELE1 TRRAP TRANK1 PEX5 CLUH TTC28 RMDN2 LRPPRC DNAJC3 | 3.07e-05 | 233 | 228 | 12 | IPR011990 |
| Domain | ASX_HYDROXYL | 3.09e-05 | 100 | 228 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.71e-05 | 106 | 228 | 8 | IPR000152 | |
| Domain | ANATO | 6.06e-05 | 7 | 228 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 6.06e-05 | 7 | 228 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.06e-05 | 7 | 228 | 3 | PS01177 | |
| Domain | ANATO | 6.06e-05 | 7 | 228 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 6.06e-05 | 7 | 228 | 3 | IPR000020 | |
| Domain | EGF_CA | 8.74e-05 | 86 | 228 | 7 | PF07645 | |
| Domain | MAGE_N | 8.99e-05 | 20 | 228 | 4 | SM01392 | |
| Domain | TLV/ENV_coat_polyprotein | 9.61e-05 | 8 | 228 | 3 | IPR018154 | |
| Domain | Growth_fac_rcpt_ | 1.30e-04 | 156 | 228 | 9 | IPR009030 | |
| Domain | MAGE_N | 1.33e-04 | 22 | 228 | 4 | PF12440 | |
| Domain | MAGE_N | 1.33e-04 | 22 | 228 | 4 | IPR021072 | |
| Domain | MAGEA3/MAGEA6 | 1.48e-04 | 2 | 228 | 2 | IPR030097 | |
| Domain | Rep_factor-A_C | 1.48e-04 | 2 | 228 | 2 | IPR013955 | |
| Domain | Rep_fac-A_C | 1.48e-04 | 2 | 228 | 2 | PF08646 | |
| Domain | EGF | 1.59e-04 | 126 | 228 | 8 | PF00008 | |
| Domain | - | 2.24e-04 | 25 | 228 | 4 | 3.10.250.10 | |
| Domain | SR | 2.24e-04 | 25 | 228 | 4 | SM00202 | |
| Domain | SRCR-like_dom | 2.62e-04 | 26 | 228 | 4 | IPR017448 | |
| Domain | SRCR_1 | 2.62e-04 | 26 | 228 | 4 | PS00420 | |
| Domain | SRCR_2 | 2.62e-04 | 26 | 228 | 4 | PS50287 | |
| Domain | Pribosyltran | 2.76e-04 | 11 | 228 | 3 | PF00156 | |
| Domain | SRCR | 3.04e-04 | 27 | 228 | 4 | IPR001190 | |
| Domain | PRTase-like | 3.64e-04 | 12 | 228 | 3 | IPR029057 | |
| Domain | PRibTrfase_dom | 3.64e-04 | 12 | 228 | 3 | IPR000836 | |
| Domain | - | 3.64e-04 | 12 | 228 | 3 | 3.40.50.2020 | |
| Domain | Ig-like_fold | IGFN1 NXPE4 OBSCN NEO1 PTPRB PXDN HMCN2 NFATC2 IGSF9 LRRN2 KDR SEMA4D HSPG2 LAG3 FSD2 HMCN1 SIGLEC1 IL4R EPB42 LRIT1 | 4.31e-04 | 706 | 228 | 20 | IPR013783 |
| Domain | 6-Pfructokinase_euk | 4.42e-04 | 3 | 228 | 2 | IPR009161 | |
| Domain | PHOSPHORYLASE | 4.42e-04 | 3 | 228 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 4.42e-04 | 3 | 228 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 4.42e-04 | 3 | 228 | 2 | IPR000811 | |
| Domain | PHOSPHOFRUCTOKINASE | 4.42e-04 | 3 | 228 | 2 | PS00433 | |
| Domain | Phosphofructokinase_CS | 4.42e-04 | 3 | 228 | 2 | IPR015912 | |
| Domain | PFK | 4.42e-04 | 3 | 228 | 2 | PF00365 | |
| Domain | Phosphorylase | 4.42e-04 | 3 | 228 | 2 | PF00343 | |
| Domain | ATP_PFK | 4.42e-04 | 3 | 228 | 2 | IPR022953 | |
| Domain | Phosphofructokinase_dom | 4.42e-04 | 3 | 228 | 2 | IPR000023 | |
| Domain | EGF_LAM_2 | 4.62e-04 | 30 | 228 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 4.62e-04 | 30 | 228 | 4 | PS01248 | |
| Domain | - | IGFN1 NXPE4 OBSCN NEO1 PTPRB PXDN NFATC2 IGSF9 LRRN2 KDR SEMA4D HSPG2 LAG3 FSD2 HMCN1 SIGLEC1 IL4R EPB42 LRIT1 | 5.22e-04 | 663 | 228 | 19 | 2.60.40.10 |
| Domain | IG | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR SEMA4D HSPG2 LAG3 HMCN1 SIGLEC1 LRIT1 | 6.99e-04 | 421 | 228 | 14 | SM00409 |
| Domain | Ig_sub | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR SEMA4D HSPG2 LAG3 HMCN1 SIGLEC1 LRIT1 | 6.99e-04 | 421 | 228 | 14 | IPR003599 |
| Domain | Laminin_G | 7.02e-04 | 58 | 228 | 5 | IPR001791 | |
| Domain | MAGE | 7.52e-04 | 34 | 228 | 4 | SM01373 | |
| Domain | EGF_Lam | 8.42e-04 | 35 | 228 | 4 | SM00180 | |
| Domain | G2F | 8.76e-04 | 4 | 228 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 8.76e-04 | 4 | 228 | 2 | PS50993 | |
| Domain | GFP | 8.76e-04 | 4 | 228 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 8.76e-04 | 4 | 228 | 2 | IPR006605 | |
| Domain | Disintegrin_CS | 8.94e-04 | 16 | 228 | 3 | IPR018358 | |
| Domain | MAGE | 9.38e-04 | 36 | 228 | 4 | PS50838 | |
| Domain | VWFC_1 | 9.38e-04 | 36 | 228 | 4 | PS01208 | |
| Domain | MHD_dom | 9.38e-04 | 36 | 228 | 4 | IPR002190 | |
| Domain | MAGE | 9.38e-04 | 36 | 228 | 4 | PF01454 | |
| Domain | - | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 9.75e-04 | 248 | 228 | 10 | 1.25.40.20 |
| Domain | ANK | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 1.07e-03 | 251 | 228 | 10 | SM00248 |
| Domain | FN3_dom | 1.10e-03 | 209 | 228 | 9 | IPR003961 | |
| Domain | ANK_REPEAT | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 1.13e-03 | 253 | 228 | 10 | PS50088 |
| Domain | VWFC_2 | 1.15e-03 | 38 | 228 | 4 | PS50184 | |
| Domain | VWC | 1.15e-03 | 38 | 228 | 4 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.15e-03 | 38 | 228 | 4 | PS50025 | |
| Domain | Laminin_EGF | 1.15e-03 | 38 | 228 | 4 | IPR002049 | |
| Domain | Ankyrin_rpt-contain_dom | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 1.17e-03 | 254 | 228 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 1.17e-03 | 254 | 228 | 10 | PS50297 |
| Domain | PI3_PI4_kinase | 1.28e-03 | 18 | 228 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.28e-03 | 18 | 228 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.28e-03 | 18 | 228 | 3 | PS00916 | |
| Domain | ADAM_CR | 1.28e-03 | 18 | 228 | 3 | PF08516 | |
| Domain | PI3/4_kinase_cat_dom | 1.28e-03 | 18 | 228 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.28e-03 | 18 | 228 | 3 | PS50290 | |
| Domain | Laminin_G_2 | 1.40e-03 | 40 | 228 | 4 | PF02210 | |
| Domain | AWS | 1.45e-03 | 5 | 228 | 2 | SM00570 | |
| Domain | Anaphylatoxin_comp_syst | 1.45e-03 | 5 | 228 | 2 | IPR018081 | |
| Domain | Laminin_domII | 1.45e-03 | 5 | 228 | 2 | IPR010307 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.45e-03 | 5 | 228 | 2 | IPR001840 | |
| Domain | AWS | 1.45e-03 | 5 | 228 | 2 | PS51215 | |
| Domain | AWS_dom | 1.45e-03 | 5 | 228 | 2 | IPR006560 | |
| Pathway | KEGG_PENTOSE_PHOSPHATE_PATHWAY | 1.80e-05 | 27 | 175 | 5 | M1386 | |
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 2.63e-10 | 7 | 232 | 5 | 18197853 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE ERV3-1 OBSCN PFKL TRRAP NEK9 HNRNPL JAK2 PTPRB PXDN TBC1D1 HPN ANKIB1 IGSF9 BAIAP3 GOLGB1 NOTCH2 RIC1 ZNF449 SEMA4D DMAC2 LAMA3 DHRS7B SPTBN4 ANKRD44 LRPPRC PPP2R3A ZFHX3 DNAJC3 VPS13B ZMYM4 CPNE7 | 5.94e-09 | 1489 | 232 | 32 | 28611215 |
| Pubmed | 6.87e-09 | 117 | 232 | 10 | 17145500 | ||
| Pubmed | IMPDH2 DOCK11 DAPK1 BCOR NEK9 DLGAP3 PEX5 FBXO45 KCNT1 GOLGB1 PRRC2B KIF13B CACNA1E ANKFY1 NOP56 SYNE1 DVL2 NSD1 WDR26 SPTBN4 LRPPRC INA RPA1 CDH11 SPATA13 | 8.51e-09 | 963 | 232 | 25 | 28671696 | |
| Pubmed | 9.60e-09 | 5 | 232 | 4 | 8037761 | ||
| Pubmed | HJURP OBSCN PFKL GCNT2 BCOR C2CD5 PSME4 BAIAP3 GOLGB1 KIF13B NOP56 BMP2K INPP5E NSD1 PHTF2 FBXO11 RHOT2 CUBN ANKRD50 RPP14 WDHD1 CEP295 KLHDC10 ESPL1 RPA1 VPS13B | 2.08e-08 | 1084 | 232 | 26 | 11544199 | |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 2.41e-08 | 14 | 232 | 5 | 8575766 | |
| Pubmed | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | 3.60e-08 | 15 | 232 | 5 | 7927540 | |
| Pubmed | 6.65e-08 | 7 | 232 | 4 | 22134685 | ||
| Pubmed | ERCC2 HJURP STK35 FZD1 FZD4 SLIT2 TBC1D1 RABGAP1L ETNK1 IGSF9 USP1 PRRC2B ANKFY1 NOP56 DVL2 NUP98 NSD1 RHOT2 SEZ6L2 PRKRA ANKS3 CDH11 ZMYM4 PRPS1 | 8.32e-08 | 1006 | 232 | 24 | 15226823 | |
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 1.32e-07 | 8 | 232 | 4 | 31149633 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 1.32e-07 | 8 | 232 | 4 | 27226137 | |
| Pubmed | 2.04e-07 | 167 | 232 | 10 | 22159717 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACLY GGT3P FBLN1 EFEMP1 PXDN HPN PYGB PYGL C4A C4B FGG HSPG2 LAMA3 SEMA5A MUC5B CUBN CFI LGALS3BP SPTBN4 THBS1 ATP6V0D1 HMCN1 CDH11 CPNE7 | 2.56e-07 | 1070 | 232 | 24 | 23533145 |
| Pubmed | 2.93e-07 | 3 | 232 | 3 | 1314091 | ||
| Pubmed | Expression of MAGE genes in primary and metastatic cutaneous melanoma. | 2.93e-07 | 3 | 232 | 3 | 7591235 | |
| Pubmed | 3.14e-07 | 175 | 232 | 10 | 28071719 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PRPS2 ERCC2 IMPDH2 ACLY HJURP PSMB7 PFKL PFKM NEK9 HNRNPL PSME4 PYGB GMDS PYGL USP1 EXOSC4 IARS1 RHOT2 XPO1 WDR26 ARCN1 LGALS3BP DHRS7B LRPPRC RPA1 PRPS1 | 3.71e-07 | 1257 | 232 | 26 | 37317656 |
| Pubmed | CSMD3 TRIL PXDN TBC1D1 RABGAP1L PCDH10 BAIAP3 PRRC2B ANKFY1 TTC28 SYNE1 ST18 VPS13B SPATA13 | 7.25e-07 | 407 | 232 | 14 | 12693553 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | SLIT2 FBLN1 EFEMP1 PXDN C4A C4B HSPG2 LAMA4 CFI LGALS3BP THBS1 | 1.00e-06 | 248 | 232 | 11 | 24006456 |
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | MAGEA3 MAGEA6 TTC23L NEK9 FZD4 HMCN2 IFRD2 BACE2 ANKFY1 BMP2K MUC5B XPO1 FANCM | 1.09e-06 | 361 | 232 | 13 | 18976975 |
| Pubmed | Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells. | 1.32e-06 | 13 | 232 | 4 | 28079882 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA4 FAM120B IMPDH2 ACLY PFKL PFKM TRRAP NEK9 HNRNPL PSME4 SERPINB12 ANKIB1 PKP1 PYGB PYGL ALOX12B ANKFY1 NOP56 IARS1 RHOT2 XPO1 ARCN1 PRKRA LRPPRC MAP4K5 RPA1 | 1.46e-06 | 1353 | 232 | 26 | 29467282 |
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 1.56e-06 | 162 | 232 | 9 | 16502470 | |
| Pubmed | ERCC2 ABCA12 BCOR TRRAP C2CD5 NSD3 SLIT2 HMCN2 HPN PEX5 VPS51 NOTCH2 PRRC2B TTC28 DVL2 RHOT2 WDR26 LGALS3BP DHRS7B ZFHX3 CEP295 SIGLEC1 ANKS3 | 1.94e-06 | 1116 | 232 | 23 | 31753913 | |
| Pubmed | 2.90e-06 | 5 | 232 | 3 | 23060442 | ||
| Pubmed | SMG1 BCOR TRANK1 FBXL7 PSME4 ANKIB1 IGSF9 KCNT1 PITRM1 INPP5E ANKRD50 URGCP ESPL1 ANKS3 ZMYM4 | 3.17e-06 | 529 | 232 | 15 | 14621295 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 4.07e-06 | 182 | 232 | 9 | 31067453 | |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 5.13e-06 | 141 | 232 | 8 | 32322062 | |
| Pubmed | FAM120B IMPDH2 ACLY NEK9 HNRNPL SERPINB12 PKP1 EXOSC4 PRRC2B ANKFY1 IARS1 WDR26 LRPPRC INA PRPS1 | 5.17e-06 | 551 | 232 | 15 | 34728620 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 5.41e-06 | 142 | 232 | 8 | 19851296 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 OBSCN TRRAP NSD3 FZD1 JAK2 PSME4 IFRD2 PYGB NOTCH2 RIC1 PRRC2B DOC2A HSPG2 INPP5E NSD1 RHOT2 MLLT10 LRP3 ESPL1 IL4R SPATA13 | 5.66e-06 | 1105 | 232 | 22 | 35748872 |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 5.70e-06 | 143 | 232 | 8 | 20198315 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | IMPDH2 ACLY PFKL SLIT2 DLGAP3 FBLN1 EFEMP1 ANKIB1 PEX5 IGSF9 VPS51 NOTCH2 SPTBN4 INA ANKS3 | 6.28e-06 | 560 | 232 | 15 | 21653829 |
| Pubmed | 6.64e-06 | 146 | 232 | 8 | 27068509 | ||
| Pubmed | 7.02e-06 | 105 | 232 | 7 | 22505724 | ||
| Pubmed | SMG1 OBSCN NEK9 NEO1 USP1 NOTCH2 HSPG2 ANKFY1 SYNE1 LAMA4 FSD2 ANKRD50 LRPPRC ZMYM4 | 7.31e-06 | 497 | 232 | 14 | 23414517 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | HAUS3 PFKL C2CD5 DLGAP3 TTC28 NUP98 CFI SEC31B THBS1 PPP2R3A ELF1 ZMYM4 PRPS1 | 7.54e-06 | 431 | 232 | 13 | 33660365 |
| Pubmed | 7.79e-06 | 41 | 232 | 5 | 16740002 | ||
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 17634428 | ||
| Pubmed | Systematic and quantitative assessment of the ubiquitin-modified proteome. | 1.18e-05 | 158 | 232 | 8 | 21906983 | |
| Pubmed | FAM120B ACLY DAPK1 PFKL PFKM DLGAP3 SCN2A PYGB C4A C4B FGG VPS51 PRRC2B ADCY4 IARS1 SYNE1 XPO1 ARCN1 PRKRA SPTBN4 LRPPRC ATP6V0D1 INA CACNA2D3 PRPS1 | 1.22e-05 | 1431 | 232 | 25 | 37142655 | |
| Pubmed | PRPS2 SMG1 PFKM PRPS1L1 PXDN KDR USP1 GOLGB1 PRRC2B DOC2A KIF13B CACNA1E KRT12 NOP56 PCDHGB5 SYNE1 NUP98 DHRS7B SPTBN4 LRPPRC INA CEP295 DNAJC3 SPATA13 PRPS1 | 1.38e-05 | 1442 | 232 | 25 | 35575683 | |
| Pubmed | 1.42e-05 | 162 | 232 | 8 | 21890473 | ||
| Pubmed | 1.42e-05 | 162 | 232 | 8 | 25826454 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PFKL TRRAP IFRD2 PKP1 PYGL USP1 FBXO45 PRRC2B KIF13B ANKFY1 TTC28 IARS1 NUP98 FBXO11 WDR26 ARCN1 DHRS7B LRPPRC ZMYM4 CPNE7 | 1.54e-05 | 1005 | 232 | 20 | 19615732 |
| Pubmed | 1.60e-05 | 8 | 232 | 3 | 24474777 | ||
| Pubmed | 1.60e-05 | 8 | 232 | 3 | 33504453 | ||
| Pubmed | 1.60e-05 | 8 | 232 | 3 | 19388021 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPS2 IMPDH2 ACLY PSMB7 PFKL PFKM NEK9 SPDL1 PSME4 PEX5 PYGB GMDS PYGL CLUH EXOSC4 ANKFY1 IARS1 DVL2 NUP98 XPO1 WDR26 ARCN1 WDHD1 RPA1 PRPS1 | 1.61e-05 | 1455 | 232 | 25 | 22863883 |
| Pubmed | IMPDH2 PSMB7 PFKM NEK9 PYGB ANKFY1 IARS1 NUP98 XPO1 WDR26 DHRS7B PRKRA LRPPRC RPA1 | 1.63e-05 | 534 | 232 | 14 | 35032548 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAGEA4 IMPDH2 NAPG PFKL PFKM HNRNPL SERPINB12 PKP1 PYGB PYGL CLUH EXOSC4 GOLGB1 PRRC2B IARS1 DVL2 NUP98 MUC5B XPO1 ARCN1 LGALS3BP PRKRA LRPPRC ATP6V0D1 | 1.69e-05 | 1367 | 232 | 24 | 32687490 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IMPDH2 ACLY PFKL TRRAP HNRNPL SLIT2 SERPINB12 PKP1 PEX5 GOLGB1 NOP56 IARS1 SYNE1 NUP98 XPO1 ARCN1 LGALS3BP LRPPRC INA RPA1 | 2.01e-05 | 1024 | 232 | 20 | 24711643 |
| Pubmed | 2.08e-05 | 124 | 232 | 7 | 23000965 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | IMPDH2 ACLY PSMB7 SLIT2 NRSN2 PXDN VPS51 IARS1 LEMD2 DVL2 NUP98 RHOT2 XPO1 URGCP ARCN1 DHRS7B LRPPRC ESPL1 DNAJC3 | 2.11e-05 | 942 | 232 | 19 | 31073040 |
| Pubmed | Pancreatic islet and progenitor cell surface markers with cell sorting potential. | 2.49e-05 | 86 | 232 | 6 | 21947380 | |
| Pubmed | 3.03e-05 | 234 | 232 | 9 | 36243803 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IMPDH2 ACLY PFKL PFKM NEK9 HNRNPL SPDL1 SERPINB12 PKP1 SGO2 CLUH ADCY4 ANKFY1 NOP56 PITRM1 IARS1 SYNE1 NUP98 XPO1 ARCN1 LRPPRC ATP6V0D1 RPA1 PRPS1 | 3.29e-05 | 1425 | 232 | 24 | 30948266 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ACLY PSMB7 PFKM HNRNPL C2CD5 DLGAP3 PTPN7 PYGL CLUH PRRC2B PITRM1 NUP98 XPO1 ANKRD50 WDR26 LRPPRC ESPL1 DNAJC3 PRPS1 | 3.32e-05 | 974 | 232 | 19 | 28675297 |
| Pubmed | Global identification of modular cullin-RING ligase substrates. | 3.44e-05 | 134 | 232 | 7 | 21963094 | |
| Pubmed | 3.82e-05 | 241 | 232 | 9 | 23125841 | ||
| Pubmed | 3.88e-05 | 93 | 232 | 6 | 27215380 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPS2 MAGEA4 IMPDH2 ACLY PFKL HNRNPL NSD3 SERPINB12 PKP1 EXOSC4 NOP56 DSG3 IARS1 NUP98 LAMA3 XPO1 ARCN1 LGALS3BP DHRS7B PRKRA LRPPRC THBS1 | 4.05e-05 | 1257 | 232 | 22 | 36526897 |
| Pubmed | PI4K2A NAPG PFKL NEK9 RABGAP1L PKP1 ANKFY1 XPO1 LRPPRC INA KLHDC10 RPA1 | 4.23e-05 | 437 | 232 | 12 | 20562859 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 4.43e-05 | 2 | 232 | 2 | 16565498 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 15998580 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 19062096 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21683323 | ||
| Pubmed | KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo. | 4.43e-05 | 2 | 232 | 2 | 34670814 | |
| Pubmed | Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms. | 4.43e-05 | 2 | 232 | 2 | 29655163 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 4.43e-05 | 2 | 232 | 2 | 19933335 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21452042 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 4.43e-05 | 2 | 232 | 2 | 2459207 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 29500156 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.43e-05 | 2 | 232 | 2 | 17645767 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 4.43e-05 | 2 | 232 | 2 | 27758680 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 22387014 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 30056111 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 4.43e-05 | 2 | 232 | 2 | 23749435 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 23918728 | ||
| Pubmed | Localization of a human brain sodium channel gene (SCN2A) to chromosome 2. | 4.43e-05 | 2 | 232 | 2 | 2571571 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 4.43e-05 | 2 | 232 | 2 | 3037333 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 11726230 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 4.43e-05 | 2 | 232 | 2 | 6950384 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21813447 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 4.43e-05 | 2 | 232 | 2 | 8428773 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 8780720 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 4.43e-05 | 2 | 232 | 2 | 21345967 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 19136612 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 18826608 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 2572548 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 2302180 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 6444532 | ||
| Pubmed | KIF13B mediates VEGFR2 recycling to modulate vascular permeability. | 4.43e-05 | 2 | 232 | 2 | 36928770 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 38180818 | ||
| Cytoband | 20p13 | 1.76e-04 | 102 | 232 | 5 | 20p13 | |
| Cytoband | Xq28 | 2.89e-04 | 176 | 232 | 6 | Xq28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 4.20e-04 | 123 | 232 | 5 | chr20p13 | |
| Cytoband | 12p12.1 | 4.22e-04 | 29 | 232 | 3 | 12p12.1 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | IGFN1 OBSCN NEO1 PXDN HMCN2 IGSF9 LRRN2 KDR HSPG2 HMCN1 SIGLEC1 LRIT1 | 1.65e-08 | 161 | 157 | 12 | 593 |
| GeneFamily | Fibulins | 3.73e-07 | 8 | 157 | 4 | 556 | |
| GeneFamily | MAGE family | 2.38e-05 | 40 | 157 | 5 | 1136 | |
| GeneFamily | Ankyrin repeat domain containing | DAPK1 BCOR TRANK1 ANKIB1 NOTCH2 ANKFY1 ANKRD50 ANKRD44 ANKS3 ANKRD7 | 5.14e-05 | 242 | 157 | 10 | 403 |
| GeneFamily | Glycogen phosphorylases | 2.24e-04 | 3 | 157 | 2 | 437 | |
| GeneFamily | Fibronectin type III domain containing | 5.01e-04 | 160 | 157 | 7 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.50e-03 | 193 | 157 | 7 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.61e-03 | 27 | 157 | 3 | 47 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.59e-03 | 9 | 157 | 2 | 1234 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.30e-03 | 115 | 157 | 5 | 769 | |
| GeneFamily | Complement system|Sushi domain containing | 3.72e-03 | 36 | 157 | 3 | 492 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 3.91e-03 | 11 | 157 | 2 | 286 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 4.02e-03 | 37 | 157 | 3 | 454 | |
| GeneFamily | Laminin subunits | 4.67e-03 | 12 | 157 | 2 | 626 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SLIT2 FBLN1 EFEMP1 PXDN HMCN2 OTOGL FGG LAMA3 LAMA4 THBS1 HMCN1 | 1.13e-06 | 191 | 231 | 11 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | SLIT2 FBLN1 EFEMP1 PXDN HMCN2 OTOGL FGG HSPG2 LAMA3 LAMA4 THBS1 HMCN1 | 5.48e-06 | 270 | 231 | 12 | MM17057 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | PRPS2 IMPDH2 PSMB7 BCOR FZD1 USP1 NOTCH2 NOP56 PITRM1 SEMA5A XPO1 CUBN CFI DDIAS PPP2R3A ZFHX3 RPA1 | 9.73e-06 | 555 | 231 | 17 | M2343 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.02e-05 | 196 | 231 | 10 | M3008 | |
| Coexpression | PILON_KLF1_TARGETS_UP | NAPG ACOX2 FZD1 PTPRB PXDN HPN ETNK1 FGG SLC39A5 RIC1 STAB2 PITRM1 BMP2K ABCC9 CFI EPB42 | 1.12e-05 | 503 | 231 | 16 | M2226 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 1.21e-05 | 200 | 231 | 10 | M9341 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN | PRPS2 TBC1D1 ANKIB1 SEMA4D ADCY4 NSD1 RPP14 LGALS3BP WDHD1 DNAJC3 | 1.21e-05 | 200 | 231 | 10 | M6299 |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 1.48e-05 | 60 | 231 | 6 | M1515 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | HJURP ACOX2 NR1I2 HPN PYGL FGG SLC39A5 CLUH SOAT2 KLB DENND5B ZAN IL17RC CUBN CFI LRPPRC | 2.39e-05 | 535 | 231 | 16 | MM3635 |
| Coexpression | PATIL_LIVER_CANCER | GABRE ACLY HJURP HAUS3 STK35 ANKIB1 PYGB USP1 FBXO45 KLB IARS1 DVL2 LAMA4 SEMA5A XPO1 SEZ6L2 MSTO1 ESPL1 | 2.51e-05 | 660 | 231 | 18 | M1195 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DAPK1 TRRAP C2CD5 SLIT2 FBXL7 PSME4 RABGAP1L SETD3 TTC28 BMP2K NUP98 SEMA5A XPO1 LRPPRC PPP2R3A WDHD1 MAP4K5 ZFHX3 KLHDC10 VPS13B ZMYM4 | 2.54e-05 | 856 | 231 | 21 | M4500 |
| Coexpression | PILON_KLF1_TARGETS_UP | NAPG ACOX2 FZD1 PTPRB PXDN HPN ETNK1 FGG SLC39A5 RIC1 STAB2 PITRM1 BMP2K ABCC9 CFI EPB42 | 2.73e-05 | 541 | 231 | 16 | MM1061 |
| Coexpression | NABA_CORE_MATRISOME | SLIT2 FBLN1 EFEMP1 PXDN HMCN2 FGG HSPG2 LAMA3 LAMA4 THBS1 HMCN1 | 3.57e-05 | 275 | 231 | 11 | M5884 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | PRPS2 RIMKLA HJURP HAUS3 BCOR NSD3 FZD1 FZD4 PXDN SGO2 USP1 PRIMPOL ZNF449 SEMA4D BMP2K PHTF2 XPO1 FANCM CEP295 DNAJC3 SPATA13 | 4.60e-05 | 892 | 231 | 21 | M18120 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 DOCK11 NEK9 MYSM1 PTPN7 TRANK1 NFATC2 TBC1D1 RABGAP1L ARHGAP25 USP1 NOTCH2 PRRC2B SEMA4D SYNE1 LAG3 NUP98 IFI44 NSD1 PHTF2 FBXO11 XPO1 WDR26 ANKRD44 ELF1 RPA1 VPS13B SPATA13 RASGRP2 | 5.55e-05 | 1492 | 231 | 29 | M40023 |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_DN | 6.97e-05 | 198 | 231 | 9 | M9018 | |
| Coexpression | GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP | 7.52e-05 | 200 | 231 | 9 | M9437 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 7.52e-05 | 200 | 231 | 9 | M10091 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 7.52e-05 | 200 | 231 | 9 | M6789 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | RIMKLA BCOR TRIL SLIT2 FBLN1 FBXL7 ARHGAP25 PCDH10 BMP2K ABCC9 THBS1 MAP4K5 CACNA2D3 | 8.00e-05 | 411 | 231 | 13 | M1351 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | GABRE ABCA9 FZD1 CSRNP1 PXDN CD163L1 NOTCH2 ADCY4 LAG3 IFI44 LAMA4 ABCC9 SEMA5A IL17RC LGALS3BP ANKRD44 PDE8B CDH11 RASGRP2 | 8.79e-05 | 795 | 231 | 19 | M39050 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | RIMKLA BCOR TRIL SLIT2 FBLN1 FBXL7 ARHGAP25 PCDH10 BMP2K ABCC9 THBS1 MAP4K5 CACNA2D3 | 9.03e-05 | 416 | 231 | 13 | MM1002 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.18e-04 | 166 | 231 | 8 | M39026 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 1.39e-04 | 170 | 231 | 8 | M5657 | |
| Coexpression | LIANG_SILENCED_BY_METHYLATION_2 | 1.59e-04 | 58 | 231 | 5 | M18085 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | DAPK1 ABCA9 FZD1 FZD4 FBLN1 NEO1 EFEMP1 PXDN C4A C4B BACE2 HSPG2 LAMA4 ABCC9 SEMA5A THBS1 HMCN1 CDH11 | 3.17e-06 | 466 | 228 | 18 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | DAPK1 ABCA9 FZD1 FBLN1 NEO1 EFEMP1 PXDN C4A C4B BACE2 HSPG2 LAMA4 ABCC9 SEMA5A THBS1 CDH11 | 3.56e-05 | 455 | 228 | 16 | GSM777055_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | DOCK11 ACLY ABCA9 FZD4 FBXL7 PTPRB PXDN KDR ARHGAP25 HSPG2 ADCY4 STAB2 BMP2K LAMA4 ABCC9 ANKRD50 RMDN2 HMCN1 MAP4K5 IL4R CDH11 SPATA13 RASGRP2 | 4.40e-05 | 846 | 228 | 23 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK11 ABCA9 FZD4 FBXL7 PTPRB KDR ARHGAP25 HSPG2 ADCY4 STAB2 BMP2K LAMA4 HMCN1 MAP4K5 IL4R SPATA13 RASGRP2 | 5.41e-05 | 523 | 228 | 17 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 7.47e-05 | 41 | 228 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 7.62e-05 | 66 | 228 | 6 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | DAPK1 ABCA9 FZD1 FZD4 SLIT2 FBLN1 NEO1 EFEMP1 PXDN C4B HSPG2 LAMA4 THBS1 HMCN1 CDH11 | 8.20e-05 | 437 | 228 | 15 | GSM777046_500 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_500 | 8.50e-05 | 97 | 228 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500_k2 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | NXPE4 GCNT2 FZD4 FBXL7 PTPRB PXDN KDR BACE2 HSPG2 ADCY4 IFI44 LAMA3 LAMA4 SEMA5A THBS1 | 1.31e-04 | 456 | 228 | 15 | GSM777032_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA12 OBSCN CSMD3 TRANK1 OTOGL SCN2A PCDH10 STAB2 ZAN MUC5B HMCN1 ST18 | 1.72e-11 | 184 | 232 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA12 OBSCN CSMD3 TRANK1 OTOGL SCN2A PCDH10 STAB2 ZAN MUC5B HMCN1 ST18 | 1.72e-11 | 184 | 232 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ABCA12 OBSCN CSMD3 TRANK1 OTOGL SCN2A PCDH10 STAB2 ZAN MUC5B HMCN1 ST18 | 1.72e-11 | 184 | 232 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA9 F10 FZD4 FBLN1 EFEMP1 FBXL7 PXDN HSPG2 LAMA4 ABCC9 CIDEC | 7.63e-09 | 197 | 232 | 11 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA9 F10 FZD4 FBLN1 EFEMP1 FBXL7 PXDN HSPG2 LAMA4 ABCC9 CIDEC | 7.63e-09 | 197 | 232 | 11 | 17344464fdcc5ba0c03959696b97c195f11e644c |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA9 F10 FZD4 FBLN1 EFEMP1 FBXL7 PXDN HSPG2 LAMA4 ABCC9 CIDEC | 7.63e-09 | 197 | 232 | 11 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | ERV3-1 LCN12 EFEMP1 PTPRB KDR MUC5B ANKRD50 CFI LGALS3BP CDH11 | 5.57e-08 | 187 | 232 | 10 | be9fce9e74b2f170a2067f1b31d802912a578329 |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 190 | 232 | 10 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 190 | 232 | 10 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 190 | 232 | 10 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 190 | 232 | 10 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.87e-08 | 194 | 232 | 10 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.87e-08 | 194 | 232 | 10 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.25e-08 | 195 | 232 | 10 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.08e-08 | 197 | 232 | 10 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.20e-08 | 149 | 232 | 9 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SLIT2 FBLN1 PCDHGB5 SYNE1 LAMA4 SEMA5A THBS1 LRP3 CDH11 SPATA13 | 9.98e-08 | 199 | 232 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SLIT2 FBLN1 PCDHGB5 SYNE1 LAMA4 SEMA5A THBS1 IL4R CDH11 SPATA13 | 9.98e-08 | 199 | 232 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-07 | 162 | 232 | 9 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.98e-07 | 177 | 232 | 9 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.04e-07 | 186 | 232 | 9 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-07 | 188 | 232 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.21e-07 | 190 | 232 | 9 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 7.21e-07 | 190 | 232 | 9 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-07 | 192 | 232 | 9 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-07 | 192 | 232 | 9 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 8.22e-07 | 193 | 232 | 9 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-07 | 194 | 232 | 9 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-07 | 195 | 232 | 9 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.35e-07 | 196 | 232 | 9 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.35e-07 | 196 | 232 | 9 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.35e-07 | 196 | 232 | 9 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.35e-07 | 196 | 232 | 9 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.35e-07 | 196 | 232 | 9 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.75e-07 | 197 | 232 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.75e-07 | 197 | 232 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.75e-07 | 197 | 232 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.02e-06 | 198 | 232 | 9 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 232 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 199 | 232 | 9 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 158 | 232 | 8 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.92e-06 | 159 | 232 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-06 | 161 | 232 | 8 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.42e-06 | 164 | 232 | 8 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-06 | 166 | 232 | 8 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.65e-06 | 166 | 232 | 8 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 168 | 232 | 8 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-06 | 171 | 232 | 8 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.76e-06 | 174 | 232 | 8 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.27e-06 | 177 | 232 | 8 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-06 | 182 | 232 | 8 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 182 | 232 | 8 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 182 | 232 | 8 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 182 | 232 | 8 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.46e-06 | 183 | 232 | 8 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.91e-06 | 185 | 232 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.91e-06 | 185 | 232 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 186 | 232 | 8 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-06 | 186 | 232 | 8 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.39e-06 | 187 | 232 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 6.39e-06 | 187 | 232 | 8 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.39e-06 | 187 | 232 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 189 | 232 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.91e-06 | 189 | 232 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 189 | 232 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 190 | 232 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.18e-06 | 190 | 232 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.47e-06 | 191 | 232 | 8 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.47e-06 | 191 | 232 | 8 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 7.76e-06 | 192 | 232 | 8 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.06e-06 | 193 | 232 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 8.06e-06 | 193 | 232 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.06e-06 | 193 | 232 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.37e-06 | 194 | 232 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.37e-06 | 194 | 232 | 8 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.37e-06 | 194 | 232 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.37e-06 | 194 | 232 | 8 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.37e-06 | 194 | 232 | 8 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.69e-06 | 195 | 232 | 8 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.69e-06 | 195 | 232 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.69e-06 | 195 | 232 | 8 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.69e-06 | 195 | 232 | 8 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.69e-06 | 195 | 232 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 195 | 232 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 195 | 232 | 8 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 197 | 232 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-06 | 197 | 232 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 9.36e-06 | 197 | 232 | 8 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.36e-06 | 197 | 232 | 8 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 197 | 232 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.36e-06 | 197 | 232 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-06 | 197 | 232 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| Drug | 2,5-anhydro-D-mannitol | 2.10e-08 | 31 | 230 | 7 | CID000001494 | |
| Drug | ribose-5-P | 2.10e-07 | 112 | 230 | 10 | CID000439167 | |
| Drug | AC1L1AO2 | 7.75e-07 | 18 | 230 | 5 | CID000001073 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | ERCC2 FZD1 FBLN1 PSME4 PKP1 NOTCH2 DET1 NUP98 MAP4K5 KLHDC10 IL4R VPS13B | 9.25e-07 | 199 | 230 | 12 | 6324_DN |
| Drug | polyribosylribitol phosphate | 2.09e-06 | 112 | 230 | 9 | CID000002219 | |
| Drug | AC1Q6RZ4 | 4.54e-06 | 123 | 230 | 9 | CID000000719 | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | PI4K2A NEK9 JAK2 PTPRB RABGAP1L LRRN2 NOTCH2 FBXO11 MLLT10 THBS1 ELF1 | 4.80e-06 | 194 | 230 | 11 | 4599_UP |
| Drug | 1-o-phosphonohex-2-ulose | 9.81e-06 | 29 | 230 | 5 | CID000000481 | |
| Drug | 6-FPLP | 1.00e-05 | 5 | 230 | 3 | CID000146246 | |
| Drug | 6-FDPL | 1.00e-05 | 5 | 230 | 3 | CID000129578 | |
| Drug | AC1L9I7L | 1.53e-05 | 79 | 230 | 7 | CID000445564 | |
| Drug | AC1L2I23 | 1.68e-05 | 16 | 230 | 4 | CID000047419 | |
| Drug | methyl iodoacetate | 1.99e-05 | 6 | 230 | 3 | CID006429536 | |
| Drug | APP-MP | 1.99e-05 | 6 | 230 | 3 | CID003081102 | |
| Drug | pyrimidine-5-nucleotide | 1.99e-05 | 6 | 230 | 3 | CID000440040 | |
| Drug | Laevuflex | PRPS2 ACLY PFKL PFKM PRPS1L1 PYGB PYGL VPS51 ADCY4 ARCN1 SIGLEC1 PRPS1 | 2.26e-05 | 272 | 230 | 12 | CID000003426 |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | ABCA12 SLIT2 HPN RABGAP1L KIF13B DVL2 PHTF2 GTDC1 PPP2R3A CIDEC | 2.96e-05 | 194 | 230 | 10 | 6794_DN |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | FZD1 PSME4 PYGB GMDS PRRC2B INPP5E SEC31B THBS1 ELF1 RASGRP2 | 3.10e-05 | 195 | 230 | 10 | 1836_DN |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 5063_DN | |
| Drug | anthranilic acid | 3.34e-05 | 89 | 230 | 7 | CID000000227 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.38e-05 | 197 | 230 | 10 | 4501_DN | |
| Drug | 6-fluoropyridoxal | 3.46e-05 | 7 | 230 | 3 | CID003080803 | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | ERCC2 GCNT2 CYP2W1 FBLN1 NRSN2 FBXL7 BAIAP3 MLLT10 SIGLEC1 VPS13B | 3.68e-05 | 199 | 230 | 10 | 6783_UP |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 3.68e-05 | 199 | 230 | 10 | 1729_UP | |
| Drug | allulose 6-phosphate | 4.15e-05 | 162 | 230 | 9 | CID000000603 | |
| Drug | DIBAH | 5.49e-05 | 8 | 230 | 3 | CID000014487 | |
| Drug | SRI 63-675 | 5.49e-05 | 8 | 230 | 3 | CID000122013 | |
| Drug | AC1L19C4 | 7.02e-05 | 69 | 230 | 6 | CID000000483 | |
| Disease | Leukemia, Myelocytic, Acute | 7.26e-06 | 173 | 223 | 9 | C0023467 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.40e-05 | 139 | 223 | 7 | DOID:3908 (is_implicated_in) | |
| Disease | sodium measurement | 1.35e-04 | 103 | 223 | 6 | EFO_0009282 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.39e-04 | 148 | 223 | 7 | C0279702 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 1.70e-04 | 3 | 223 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | Drusen, Radial, Autosomal Dominant | 1.70e-04 | 3 | 223 | 2 | C1852021 | |
| Disease | Malattia Leventinese | 1.70e-04 | 3 | 223 | 2 | C1852020 | |
| Disease | limited scleroderma (is_marker_for) | 1.70e-04 | 3 | 223 | 2 | DOID:1577 (is_marker_for) | |
| Disease | tubulointerstitial nephritis antigen-like measurement | 1.70e-04 | 3 | 223 | 2 | EFO_0803197 | |
| Disease | EGF-containing fibulin-like extracellular matrix protein 1 measurement | 1.70e-04 | 3 | 223 | 2 | EFO_0022022 | |
| Disease | breast angiosarcoma (is_implicated_in) | 1.70e-04 | 3 | 223 | 2 | DOID:4511 (is_implicated_in) | |
| Disease | DOYNE HONEYCOMB RETINAL DYSTROPHY | 1.70e-04 | 3 | 223 | 2 | C1832174 | |
| Disease | Ichthyosis Congenita I | 3.38e-04 | 4 | 223 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 3.38e-04 | 4 | 223 | 2 | C0239849 | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 3.38e-04 | 4 | 223 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | Ichthyosis Congenita II | 3.38e-04 | 4 | 223 | 2 | C3536797 | |
| Disease | glycogen storage disease (implicated_via_orthology) | 3.38e-04 | 4 | 223 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | Collodion Fetus | 3.38e-04 | 4 | 223 | 2 | C3543867 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.87e-04 | 125 | 223 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.87e-04 | 125 | 223 | 6 | C1879321 | |
| Disease | ovarian serous carcinoma | 4.04e-04 | 46 | 223 | 4 | EFO_1001516 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.39e-04 | 128 | 223 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C0007134 | |
| Disease | prothrombin time measurement | 5.12e-04 | 21 | 223 | 3 | EFO_0008390 | |
| Disease | disease of metabolism (implicated_via_orthology) | 5.12e-04 | 21 | 223 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Fibrinogen Deficiency | 5.60e-04 | 5 | 223 | 2 | C4316812 | |
| Disease | Congenital ichthyosis | 5.60e-04 | 5 | 223 | 2 | C0020758 | |
| Disease | brain glioma (is_marker_for) | 5.60e-04 | 5 | 223 | 2 | DOID:0060108 (is_marker_for) | |
| Disease | ovarian carcinoma | 8.00e-04 | 321 | 223 | 9 | EFO_0001075 | |
| Disease | uric acid measurement | GCNT2 NSD3 NFATC2 PYGB GMDS VPS51 PRRC2B KLB CUBN ANKRD50 MAP4K5 RPA1 CACNA2D3 | 8.12e-04 | 610 | 223 | 13 | EFO_0004761 |
| Disease | galectin-3-binding protein measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0010241 | |
| Disease | cortical thickness | SLIT2 NEO1 FBXL7 PYGB IGSF9 SETD3 CLUH SEMA4D HSPG2 INPP5E FSD2 ABCC9 DNAAF9 MLLT10 RAB44 THBS1 ST18 CDH11 CACNA2D3 | 8.50e-04 | 1113 | 223 | 19 | EFO_0004840 |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 8.64e-04 | 97 | 223 | 5 | EFO_0007878, EFO_0009458 | |
| Disease | platelet crit | PSMB7 STK35 C2CD5 JAK2 CSRNP1 PTPN7 HPN LRRN2 ARHGAP25 TTC28 LEMD2 CUBN RPP14 THBS1 MAP4K5 ELF1 SPATA13 | 9.80e-04 | 952 | 223 | 17 | EFO_0007985 |
| Disease | Adenoid Cystic Carcinoma | 9.91e-04 | 100 | 223 | 5 | C0010606 | |
| Disease | Glycogen Storage Disease | 1.09e-03 | 27 | 223 | 3 | C0017919 | |
| Disease | macular degeneration (is_implicated_in) | 1.09e-03 | 27 | 223 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.16e-03 | 7 | 223 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 1.41e-03 | 160 | 223 | 6 | C0004238 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.55e-03 | 8 | 223 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Carcinoma, Granular Cell | 1.92e-03 | 116 | 223 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.92e-03 | 116 | 223 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.92e-03 | 116 | 223 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.92e-03 | 116 | 223 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.92e-03 | 116 | 223 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.92e-03 | 116 | 223 | 5 | C0001418 | |
| Disease | Complement deficiency disease | 1.97e-03 | 33 | 223 | 3 | C0272242 | |
| Disease | blood phosphate measurement | 2.15e-03 | 174 | 223 | 6 | EFO_0010972 | |
| Disease | stomach cancer (is_implicated_in) | 2.19e-03 | 72 | 223 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | protein intake measurement | 2.46e-03 | 10 | 223 | 2 | EFO_0010810 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.62e-03 | 181 | 223 | 6 | DOID:684 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.66e-03 | 76 | 223 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 2.74e-03 | 37 | 223 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | endometrial neoplasm | 2.99e-03 | 11 | 223 | 2 | EFO_0004230 | |
| Disease | pulmonary fibrosis | 2.99e-03 | 11 | 223 | 2 | EFO_0009448 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 2.99e-03 | 11 | 223 | 2 | C0079154 | |
| Disease | phosphatidylcholine 32:0 measurement | 2.99e-03 | 11 | 223 | 2 | EFO_0010372 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 2.99e-03 | 11 | 223 | 2 | C1335302 | |
| Disease | Congenital ichthyosis of skin | 2.99e-03 | 11 | 223 | 2 | cv:C0020758 | |
| Disease | Malignant neoplasm of breast | MAGEA4 OBSCN HNRNPL EFEMP1 OTOGL KDR GOLGB1 NOTCH2 SYNE1 NUP98 CUBN MCOLN1 THBS1 INA KLHDC10 VPS13B PRPS1 | 3.45e-03 | 1074 | 223 | 17 | C0006142 |
| Disease | bitter alcoholic beverage consumption measurement | 3.46e-03 | 133 | 223 | 5 | EFO_0010092 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.57e-03 | 12 | 223 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 3.57e-03 | 12 | 223 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 3.57e-03 | 12 | 223 | 2 | DOID:3963 (is_marker_for) | |
| Disease | alcohol consumption measurement, alcohol drinking | 3.57e-03 | 12 | 223 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.82e-03 | 84 | 223 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Autistic Disorder | 3.85e-03 | 261 | 223 | 7 | C0004352 | |
| Disease | IGF-1 measurement | JAK2 KLB DENND5B STAB2 DET1 NUP98 LRPPRC PPP2R3A MAP4K5 IL4R | 4.21e-03 | 488 | 223 | 10 | EFO_0004627 |
| Disease | grey matter volume measurement | 4.49e-03 | 44 | 223 | 3 | EFO_0005420 | |
| Disease | depressive symptom measurement, response to antidepressant | 4.51e-03 | 88 | 223 | 4 | EFO_0007006, GO_0036276 | |
| Disease | Malignant neoplasm of salivary gland | 4.78e-03 | 45 | 223 | 3 | C0220636 | |
| Disease | Obesity | 4.81e-03 | 205 | 223 | 6 | C0028754 | |
| Disease | trimethylamine-N-oxide measurement | 4.87e-03 | 14 | 223 | 2 | EFO_0010541 | |
| Disease | Salivary Gland Neoplasms | 5.41e-03 | 47 | 223 | 3 | C0036095 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.60e-03 | 15 | 223 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 5.60e-03 | 15 | 223 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.60e-03 | 15 | 223 | 2 | C0154091 | |
| Disease | reticulocyte count | ACLY PSMB7 ODAD4 PFKM F10 IFRD2 GMDS C4B BAIAP3 SEMA4D BMP2K LAMA3 LAMA4 DNAAF9 MAP4K5 EPB42 | 6.14e-03 | 1045 | 223 | 16 | EFO_0007986 |
| Disease | tuberculosis | 6.17e-03 | 216 | 223 | 6 | MONDO_0018076 | |
| Disease | Congenital total cataract | 6.36e-03 | 16 | 223 | 2 | C0266539 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.36e-03 | 16 | 223 | 2 | C0038015 | |
| Disease | myopia (is_implicated_in) | 6.36e-03 | 16 | 223 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.36e-03 | 16 | 223 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.36e-03 | 16 | 223 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 6.36e-03 | 16 | 223 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 6.36e-03 | 16 | 223 | 2 | C0025237 | |
| Disease | Paroxysmal atrial fibrillation | 6.77e-03 | 156 | 223 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 6.77e-03 | 156 | 223 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.77e-03 | 156 | 223 | 5 | C2585653 | |
| Disease | alpha fetoprotein measurement | 7.07e-03 | 100 | 223 | 4 | EFO_0010583 | |
| Disease | heart disease (biomarker_via_orthology) | 7.18e-03 | 17 | 223 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 7.18e-03 | 17 | 223 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Van Buchem disease | 7.18e-03 | 17 | 223 | 2 | C0432272 | |
| Disease | Acute myeloid leukemia | 7.18e-03 | 17 | 223 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 7.18e-03 | 17 | 223 | 2 | 601626 | |
| Disease | Colorectal Carcinoma | ERCC2 ABCA12 OBSCN CSMD3 ABCA9 FZD4 EFEMP1 KDR SYNE1 CUBN ZMYM4 PRPS1 | 7.46e-03 | 702 | 223 | 12 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLLAQEEGVCGKFNL | 556 | Q14264 | |
| NQNGLIYLGTADCIQ | 161 | P16452 | |
| INLDGNGQEAYASSC | 1401 | P53355 | |
| DQCLNSALGCYDGNV | 631 | Q99424 | |
| LEIGGQSLNLDCREY | 281 | Q9Y5Z0 | |
| NVACLDLGFQQGADT | 151 | P05156 | |
| GADILNSYAGLACVE | 41 | P32519 | |
| GDVVSFQCDQGYSLQ | 2071 | Q7Z407 | |
| SGQNENERCGTDLAY | 1686 | Q15878 | |
| ACAQLNDFLQEYGTQ | 1726 | P0C0L5 | |
| GTQLGQDVCEATLFY | 766 | O94812 | |
| LDRCSNQGIEDYGVS | 766 | Q8IUA7 | |
| CFGYGLIELSQQQSV | 2151 | Q86UK0 | |
| VAGYQDSIGQLENDL | 351 | Q16352 | |
| LGLNVGLTYDDITQC | 321 | Q9Y3Q7 | |
| RCSIDEYNQFLQEGG | 416 | O75078 | |
| VCSYVDALIQQGQGD | 261 | Q8TAV3 | |
| ALINGDENLACQIYE | 11 | Q9P2G1 | |
| ANAVLFLCGNVAGVY | 176 | Q8NFM4 | |
| LALDYLLAEQGGVCA | 386 | B6SEH9 | |
| CGNNISSYNINDGVL | 6 | O60706 | |
| VAQICRSGLLQGYED | 131 | Q9ULJ7 | |
| AGDCDINYEGLDNLL | 131 | Q9NW81 | |
| EDVGVNCYGEANLGL | 141 | Q9NR16 | |
| LLQGYEGEILSNGND | 96 | Q7L5Y6 | |
| ILLNDGGNYVLCDFG | 186 | Q9NSY1 | |
| LLEYGADVNCSAQDG | 1516 | Q6W2J9 | |
| LVDLQYEGAECGVNA | 21 | Q13217 | |
| GCESYLVNLSLNDND | 511 | O14641 | |
| GEQYLDCINNVAHVG | 46 | Q8TBG4 | |
| GNLSLCETALDQGYS | 1396 | Q9P241 | |
| ILLQGAEYFECAGNR | 156 | Q8NCD3 | |
| QDVIYNTTDGLGACL | 1271 | Q9HC84 | |
| GTELTFNYNLECLGN | 2051 | Q96L73 | |
| SGEYVCRANNNIDAL | 2691 | P98160 | |
| GQQLAQELGVYFGEC | 961 | Q7Z6P3 | |
| LAFDQACNLDVGGII | 281 | Q8IXN7 | |
| QVLLQGEDRLYLNCG | 421 | Q4ADV7 | |
| GEDRLYLNCGEASQT | 426 | Q4ADV7 | |
| LNYGVCVCGDENILV | 611 | O60674 | |
| VCLGRAQSQEDGDYI | 136 | P35236 | |
| IFNDLGSGSNIDLCV | 206 | Q99436 | |
| GAEESELQAYIAQCQ | 531 | Q9GZU1 | |
| GLEETVQCLLEFGAN | 781 | Q9P2R3 | |
| GQEANDCLLIYDNEG | 806 | P32926 | |
| GIVTAEDLNNYCAEL | 246 | A6NGU5 | |
| ERQDTDSCLVYGGQQ | 581 | Q13469 | |
| CLNDGRCIDLVNGYQ | 616 | Q04721 | |
| QVLQADGGTYAACVN | 126 | Q9NPD3 | |
| GAAIQEELGYNCQTG | 101 | O00567 | |
| GANGDVDQYEIQLLF | 841 | P23467 | |
| SAQCEGVLQASYAGQ | 1541 | P52948 | |
| NGLDVGYNLLCDVGA | 126 | Q8IZ02 | |
| CLGLSYDGLLGDNQV | 181 | P43356 | |
| CLGLSYDGLLGDNQI | 181 | P43357 | |
| TCLGLSYDGLLGNNQ | 181 | P43358 | |
| CLGLSYDGLLGDNQI | 181 | P43360 | |
| CLGLSYDGLLGDNQI | 181 | P43365 | |
| GQLTCVYNLGDREAE | 2456 | Q16787 | |
| AEGDYCAQLSQVQQL | 376 | Q99456 | |
| EALGQIFDSQRGCDL | 141 | Q08380 | |
| NTTLLIELEYCNGGN | 121 | Q8TD19 | |
| YLGQLECFSLGNLDA | 231 | O60547 | |
| LSAFGDLDQNQDGCI | 461 | Q7LDG7 | |
| QDLYVIGVQEGCSDR | 331 | Q9NRR6 | |
| LYNFLAIQAGNFECG | 276 | Q8NC56 | |
| DQFICLGRAQGLSDD | 161 | Q6JVE5 | |
| ENANLDASCFLNGGL | 456 | Q96S65 | |
| QTFYISIVDLCENGG | 176 | Q9NZQ0 | |
| YGGISRLQADLNCLE | 161 | Q8N0V5 | |
| QEGDSGLYSCRAENQ | 1406 | Q8NDA2 | |
| EAGLYTCVAQNLVGA | 491 | O75325 | |
| DGLTAQQLFNCGDGL | 16 | P12268 | |
| FEGLNITKLYDGQCE | 81 | P0C7L1 | |
| AYEAERQLCLENGGF | 61 | Q8IYD8 | |
| NLDSLLQCGIIYADN | 846 | Q5JUK3 | |
| GLYQCDTELLGLSAQ | 1111 | Q9BY66 | |
| IGVDGIQQFCDDLSL | 81 | Q6PH85 | |
| LALDYLLAEQGGVCA | 386 | B6SEH8 | |
| ALGCQQYTQFISGEE | 161 | Q32ZL2 | |
| NDVFICGGYNGEVIL | 326 | Q6PID8 | |
| LLQELQSLAQCYQGG | 551 | Q9BUK6 | |
| LNIAGLVGSIDNDFC | 156 | P17858 | |
| LNIVGLVGSIDNDFC | 156 | P08237 | |
| QCGLGVLFNLSGEYD | 491 | P50542 | |
| FLCNAGSELAVLYND | 666 | O95263 | |
| SQLADFCQVGLGLEL | 341 | Q8N8M0 | |
| SLNNKYLNGCGEISV | 571 | Q8IXT1 | |
| NRCLVYLDIGGNDIG | 301 | Q0VAA2 | |
| YIRGKLGQASCQADE | 156 | O75074 | |
| LEKYQEACENGRGAI | 581 | P18074 | |
| QRLIASYCNVGDIEG | 201 | P42704 | |
| LCYNDTFESLVLNGN | 131 | P78334 | |
| QCQLYQGERLLGAAV | 411 | P18627 | |
| ACYNGQDAVVNELID | 246 | Q8N8A2 | |
| YCLEDTAGGFQQLLL | 306 | O75469 | |
| LDQRAADYNQALGTC | 101 | Q9GZP1 | |
| CASDLDLGLNGQVSY | 471 | Q9Y5G0 | |
| DEGANAQLAYSILEC | 491 | Q9P2E7 | |
| VDLDLLCGHYNNDGN | 156 | Q06190 | |
| IISNDVCNGADFYGN | 316 | P05981 | |
| LDSGDYICQAKNFLG | 321 | Q9P2V4 | |
| DIGYCQGQSFLAAVL | 616 | Q5R372 | |
| QLQDGGEYTCVASNV | 951 | Q96RW7 | |
| VVQQAGQADAGEYTC | 1316 | Q5VST9 | |
| VQQAGQAVAGEYSCE | 1501 | Q5VST9 | |
| ALEGGEALFECQLSQ | 4351 | Q5VST9 | |
| RDCLVLNQGYLSEAG | 181 | Q9BTU6 | |
| SGFIQDALGNCIDIN | 296 | P23142 | |
| AEAILGQNAAYLGEL | 536 | P27694 | |
| PNGDSSCNQGDYLVL | 2141 | O60494 | |
| NQQFLVYCEIDGSGN | 201 | P02679 | |
| DVLSGVCFVGLNNVD | 471 | Q9UP38 | |
| DELTGLCYVGNQNLD | 371 | Q9ULV1 | |
| LCYVGNQNLDALTGF | 376 | Q9ULV1 | |
| ECYDAVNLIGDQFGN | 521 | Q9UKF2 | |
| VNLIGDQFGNCEITG | 526 | Q9UKF2 | |
| LGDKCLDGVLNNNSY | 541 | Q96EP1 | |
| FLGGYCSLLQQLRDD | 366 | Q14674 | |
| CSLLQQLRDDGVYGG | 371 | Q14674 | |
| FLDLLGEENGGFCQQ | 411 | P24394 | |
| GLCRDDIFYILNGNI | 261 | Q8TCB0 | |
| QVYLNGEFVGGCDIL | 111 | Q86SX6 | |
| CHDLTFNILGQIGDN | 371 | Q5JSL3 | |
| GISCYLKELEQAEQG | 231 | Q14183 | |
| DETVNCYLIDNNGFI | 851 | Q8IZS8 | |
| QCQGYVALLGSDDQS | 181 | P0C2W1 | |
| IEGNDIYGNALAGIQ | 561 | Q86XK2 | |
| VYNSGLGCIEDNEIF | 691 | Q86XK2 | |
| ITGQGLQIVAANCFD | 441 | Q9UJT9 | |
| DECEGIQGVVEAYQN | 461 | Q9UBL6 | |
| ELNQQLEAVCGSVFG | 466 | O95886 | |
| DVNGALLSCNAEAYI | 596 | P55287 | |
| NEGCRELANYLLFGL | 61 | Q5TEA3 | |
| LCGENGLVAALEQVF | 1121 | Q6ZUT9 | |
| CDTLYQGGNQLLLSD | 511 | Q68CZ6 | |
| LQQGVELCYEGIVDS | 211 | Q92527 | |
| GTCLQAELEKGNIYL | 301 | O75342 | |
| LGLGCYVAAADIQDL | 251 | Q12894 | |
| SCGNESIAYFLLQQG | 111 | Q6ZW76 | |
| DVLGACNAVNYAADN | 146 | P14866 | |
| QAYAGLCFQELGDLV | 671 | Q86Z14 | |
| QEGDEAQGYVVELCS | 871 | Q86VF2 | |
| QCFGYVDILVNNAGI | 131 | Q6IAN0 | |
| TFNNGLCYEFIQGEA | 201 | Q9HBU6 | |
| LLINEENEGFCGGTI | 251 | P00742 | |
| CGLDTARQEYLGNSL | 226 | Q4AE62 | |
| TENIIGGSEQCFEQL | 2161 | Q9C0D2 | |
| GNAVVGYLQCFDLEG | 216 | Q86YS7 | |
| GNGCDVNIEYELQED | 386 | P48444 | |
| ACAQLNDFLQEYGTQ | 1726 | P0C0L4 | |
| GEALRCYQQSAALGN | 406 | Q14154 | |
| YGLQHNCLGILGEDT | 166 | Q96EK7 | |
| RLGEYLLQDLQSGQC | 501 | Q8NAC3 | |
| ALQELYGVNCSAEDV | 141 | Q96LW4 | |
| QSNGCIEALLLGIYN | 96 | Q8IXS8 | |
| VAAVEKNGGYNQLCD | 186 | Q9Y4K4 | |
| LCGNYNDIQSDDFII | 256 | Q3ZCN5 | |
| NGGIDECTLYKCLEN | 1881 | Q3ZCN5 | |
| GFVGCLELATLNNDV | 1001 | Q16363 | |
| LVQGSLYLVICGQDD | 11 | O95157 | |
| EICLTLYGDGAANQG | 186 | P29803 | |
| DESAKQQVYQLGGIC | 276 | Q13835 | |
| ILGSFICQCNQGYEL | 271 | Q12805 | |
| KCLGENILQNAFDGY | 81 | Q9NQT8 | |
| DQGLFIQCLIGAYDQ | 41 | Q8N3S3 | |
| IDQLQSDYQDLCSIG | 3896 | Q8NF91 | |
| NGQEKYLILCEVGTD | 461 | Q8IXI1 | |
| NAELCQYLDNRDQEG | 226 | Q6UWF7 | |
| DELVGNLYSCIGNAQ | 316 | Q96NG3 | |
| NLYSCIGNAQIELGQ | 321 | Q96NG3 | |
| EALYGQLVSCGENLD | 286 | A1L4K1 | |
| YGLDQLENCQTCGTD | 481 | Q96Q15 | |
| QVLGLVKSDEGFYQC | 396 | Q92859 | |
| GCGLLDYREQAQQIE | 626 | Q5JRX3 | |
| ACVNNSALGGEVYRL | 466 | Q96EA4 | |
| NGLITTGYNLEDDRC | 281 | Q86TU7 | |
| QLCDQVSAYGFITEG | 531 | Q9NSC7 | |
| DNGNLCDYDTQNILE | 871 | Q562F6 | |
| AVLCGYVSEFEGLQN | 266 | Q96LZ7 | |
| AYVNLNICANGSEQG | 1081 | P41252 | |
| ELQEALGSGNLLNYC | 436 | Q9NQW1 | |
| VLCNNNISEGEGYVE | 171 | Q6UXD5 | |
| IFNLSEGDSGVYQCL | 611 | Q92854 | |
| EDVYIVQSGCGEIND | 51 | P21108 | |
| VGENTLCESQYLAGE | 116 | Q9BYC2 | |
| NNESGLVSCYFGQLL | 86 | Q96P63 | |
| EDCLNGSQLLVNFGL | 156 | Q6ZMH5 | |
| LFLGQGIQVSLYCQE | 481 | O75908 | |
| QCGTVDQGLYVNLTE | 356 | Q13591 | |
| LVNAAFYQALCDQEG | 651 | O60284 | |
| TICDLGGVNELANYG | 291 | P53396 | |
| LLCEEEGNGADNVQY | 176 | P55197 | |
| SCYLQQLLDATEEGQ | 206 | Q96AQ7 | |
| EGCELINEALNLFNN | 996 | O75153 | |
| YGNECGENIFEESIL | 201 | P17032 | |
| EIGSCFLQNQEGFAI | 316 | Q96N96 | |
| QLITVAEGFSQDLGC | 731 | Q8TCY9 | |
| EYDQCGEAFSQILNL | 76 | Q8TBZ8 | |
| FVGGLCQVAAAYQEL | 311 | Q9UID3 | |
| NLLDNVVNCLYHGEG | 26 | O14980 | |
| EFCEGGDLNQYVLSR | 316 | Q8TDR2 | |
| IDGDGILNERDNCQY | 801 | P07996 | |
| ENETDGQINLGCLLY | 151 | Q8N4P2 | |
| DCAALEQLLEGYDQQ | 231 | Q99747 | |
| TGFDGDQCLGVQLLE | 591 | O75717 | |
| EDVYIIQSGCGEIND | 51 | P11908 | |
| QYEGFLLCGQLTNAD | 251 | P42331 | |
| LDYLDDQQLQNGSCA | 401 | Q7L0X0 | |
| SLLDQEVGYCQGLSF | 881 | Q86TI0 | |
| GVALHDQGQYECQAV | 491 | Q92626 | |
| DQGQYECQAVNIIGS | 496 | Q92626 | |
| FYFLEGQNDALLCGN | 326 | Q99250 | |
| VNLGLQNACDEAIYQ | 101 | P11216 | |
| QNACDEAIYQLGLDL | 106 | P11216 | |
| QFDLNYGSAIIENCG | 1531 | Q5JSZ5 | |
| QGVAELAQALAAEGY | 486 | Q9H254 | |
| NNRGVCLDQYSATGE | 1971 | Q8WWQ8 | |
| LQLDYNQISCIEDGA | 156 | O94813 | |
| DEGVYICEASNTLGQ | 1061 | Q9BZZ2 | |
| YKGGVCELQVSENDL | 201 | Q6PF05 | |
| IIALGNEDALGEYSC | 381 | Q9P2J2 | |
| DACRLYVLQGGLAQQ | 1461 | Q14997 | |
| ELTFNYNLDCLGNGR | 1256 | Q9BZ95 | |
| IDELSANGQYQCLAE | 261 | O75569 | |
| LCIAQELSDYAAQGR | 501 | Q96AY4 | |
| DNETDGQVNLGCLLY | 151 | Q86WT1 | |
| LLNGYLNEEGNFEVQ | 2261 | Q7Z7G8 | |
| EICCGDLQLDNQLYN | 3446 | Q7Z7G8 | |
| EDVYIVQSGCGEIND | 51 | P60891 | |
| GNLTDEGQQYCCRLV | 251 | Q6PGP7 | |
| NASLQDQGDYVCLAQ | 631 | P35968 | |
| IIQNEYCNGGSLQAA | 286 | P0C1S8 | |
| CFGEGENLPEALQNI | 336 | P17022 | |
| QRGQFYQCDLDGNLL | 466 | Q9H7D7 | |
| EALDICYQTGQLSGI | 1971 | O15050 | |
| LEFQDCGVGLNAAQF | 26 | O95059 | |
| INLGLQNACDEAIYQ | 101 | P06737 | |
| QNACDEAIYQLGLDI | 106 | P06737 | |
| QVNYGNICTGLEVLS | 2161 | Q9Y4A5 | |
| ELNYGATGECQNFLD | 171 | Q6P9G9 | |
| CLGIQQYLFENGRID | 1311 | Q5VZL5 | |
| VGLNNLGNTCYLNSI | 81 | O94782 | |
| SEADIQQLYGGLLAN | 1456 | Q15911 | |
| LCGLCGNYNNNSLDD | 1676 | Q9Y493 | |
| CEFGGLYQALCQALQ | 2171 | Q9Y493 | |
| GVLSQADYLNLVQCE | 26 | P61421 | |
| AELNGSIGNYCQDVT | 1931 | Q14789 | |
| LYEFNILQKINDCGG | 516 | Q86W25 | |
| TYLELIGAINFGCEQ | 451 | Q5VVJ2 |